Summary
Hexobarbital was given to anaesthetized mice for a period of 7 h by repeated i. p. injection, first of 100 mg/ kg, then several times of 50 mg/kg. A high level of hexobarbital was maintained in the liver. The activity of microsomal drug-metabolizing enzymes was induced by this treatment with hexobarbital. 30 min after a single i. p. injection of 100 mg/kg of hexobarbital, there was a significant inhibition of aminopyrine N-demethylase but none of cytochrome c and neotetrazolium reductases.—Hexobarbital in vitro inhibits aminopyrine N-demethylase but not cytochrome c reductase.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
H. Remmer, Naturwissenschaften45, 189 (1958); Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.235, 279 (1959).
H. Remmer, Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.237, 296 (1959).
A. H. Conney and J. J. Burns, Nature, Lond.184, 363 (1959).
A. H. Conney, C. Davidson, R. Gastel and J. J. Burns, J. Pharmac. exp. Ther.130, 1 (1960).
H. Remmer, Archs int. Pharmacodyn.152, 346 (1964).
D. Neubert and H. Herken, Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.225, 453 (1955).
H. Coper, G. Deyhle, D. V. Herrath and J. Veit, Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.260, 366 (1968).
D. M. Serrone and J. M. Fujimoto, J. Pharmac. exp. Ther.133, 12 (1961); Biochem. Pharmac.11, 609 (1962).
C. L. Rümke and J. Bout, Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.240, 218 (1960).
E. S. Vesell, C. J. Lee, G. T. Passanati and C. A. Shively, Pharmacology8, 217 (1972).
J. R. Fouts and B. B. Brodie, J. Pharmac. exp. Ther.115, 68 (1955).
F. E. Beyhl and E. Lindner, Experientia32, 362 (1976).
E. Arrigoni-Martelli and M. Kramer, Med. exp.1, 45 (1959).
L. Ther, Grundlagen der experimentellen Arzneimittelforschung, p. 39. Wissenschaftliche Verlagsges., Stuttgart 1965.
D. B. Goldstein and A. Goldstein, Biochem. Pharmac.8, 48 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindner, E., Beyhl, F.E. Induction of microsomal drug-metabolizing enzymes caused by hexobarbital. Experientia 34, 226–227 (1978). https://doi.org/10.1007/BF01944693
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01944693